Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Denis Campbell and agency

Breast cancer drug blocked for NHS use in England and Wales after talks collapse

A bottle and box labelled Enhertu
AstraZeneca's cancer medicine Enhertu, a drug developed jointly with Japan's Daiichi Sankyo. Photograph: Astra Zeneca/Reuters

A breast cancer charity has said it was “beyond devastated” that talks to make a life-extending drug available on the NHS to women with a terminal diagnosis have collapsed.

The National Institute for Health and Care Excellence (Nice) said it had not been able to reach agreement with the makers of Enhertu so that it could approve its use in England and Wales.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.